| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 25 |
| 1 | ADALIMUMAB | 23 |
| 2 | FUROSEMIDE | 23 |
| 3 | GABAPENTIN | 16 |
| 4 | ASPIRIN | 14 |
| 5 | ASPIRIN 325 MG | 14 |
| 6 | ASPIRIN 81 MG | 14 |
| 7 | PREDNISONE | 14 |
| 8 | CYCLOPHOSPHAMIDE | 13 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THROMBIN TOPICAL RECOMBINANT | 1 | 0.0147 |
| 1 | GLIPIZIDE AND METFORMIN HCL | 1 | 0.0143 |
| 2 | THROMBIN HUMAN AND FIBRINOGEN | 1 | 0.0030 |
| 3 | FOSCARNET SODIUM | 9 | 0.0022 |
| 4 | CLINDAMYCIN PHOSPHATE | 10 | 0.0018 |
| 5 | MEPIVACAINE HYDROCHLORIDE | 2 | 0.0017 |
| 6 | CLINDAMYCIN PHOSPHATE TOPICAL | 5 | 0.0014 |
| 7 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 1 | 0.0013 |
| 8 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0011 |
| 9 | CEFTAZIDIME | 8 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 28 |
| 1 | Loop Diuretic [EPC] | 27 |
| 2 | Factor Xa Inhibitor [EPC] | 26 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 4 | beta-Adrenergic Blocker [EPC] | 16 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 14 |
| 6 | Alkylating Drug [EPC] | 13 |
| 7 | Cardiac Glycoside [EPC] | 13 |
| 8 | Azole Antifungal [EPC] | 12 |
| 9 | Kinase Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 9 | 0.0004 |
| 3 | Recombinant Human Growth Hormone [EPC] | 8 | 0.0004 |
| 4 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 5 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 7 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 8 | Cardiac Glycoside [EPC] | 13 | 0.0002 |
| 9 | Bile Acid [EPC] | 4 | 0.0002 |